BOOK
Cough: An Interdisciplinary Problem, An Issue of Otolaryngologic Clinics - E-Book
Kenneth W. Altman | Richard S. Irwin
(2010)
Additional Information
Book Details
Abstract
Both acute and chronic cough are responsible for a significant number of ambulatory medical visits annually. The recent comprehensive understanding that “cough is a reflection of underlying disease pays tribute to the multifactorial causes, as well recognition of the respiratory and upper digestive tract as a “physiologic unit. This publication highlights the advances made in managing cough and brings these to otolaryngology practitioners in a concise forum, as well as presenting issues of special interest to laryngologists such as paradoxical vocal fold motion, disordered breathing, irritable larynx, evolution of the vagus as a protective circuit, the importance of cough in deglutition, and surgical interventions. Some of the topics include: The cough reflex, sensory receptors, and neurogenic mediators; Mucus and mucins; Cough and Swallowing dysfunction; Cough due to asthma, cough-variant asthma, and nonasthmatic eosinophilic bronchitis; Occupational, environmental, and irritant induced cough; Pharmacologic management; Unexplained cough; Cough in the pediatric population; and Rhinogenic laryngitis, cough and the unified airway; among others.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Contributors | iii | ||
| Contents | vii | ||
| Cough Specialists Collaborate for an Interdisciplinary Problem | xv | ||
| Chapter 1. Cough: A Worldwide Problem | 1 | ||
| EPIDEMIOLOGY | 1 | ||
| COMPLICATIONS OF COUGH | 2 | ||
| CLASSIFYING COUGH ACCORDING TO DURATION | 2 | ||
| DIFFERENTIAL DIAGNOSIS FOR ACUTE COUGH | 2 | ||
| DIFFERENTIAL DIAGNOSIS FOR SUBACUTE COUGH | 4 | ||
| DIFFERENTIAL DIAGNOSIS FOR CHRONIC COUGH | 5 | ||
| CHRONIC BRONCHITIS | 6 | ||
| ANGIOTENSIN-CONVERTING ENZYME INHIBITORS | 6 | ||
| COMMON CLINICAL PROFILE | 6 | ||
| SUMMARY | 10 | ||
| REFERENCES | 10 | ||
| Chapter 2. Afferent Nerves Regulating the Cough Reflex: Mechanisms and Mediators of Cough in Disease | 15 | ||
| CHEMICAL AND MECHANICAL STIMULI THAT INITIATE COUGHING | 15 | ||
| AFFERENT NERVES REGULATING THE COUGH REFLEX | 17 | ||
| RAPIDLY ADAPTING RECEPTORS | 19 | ||
| COUGH RECEPTORS | 20 | ||
| AFFERENT NERVE INTERACTIONS IN COUGH AND MECHANISMS OF COUGH IN DISEASE | 20 | ||
| SUMMARY | 21 | ||
| REFERENCES | 22 | ||
| Chapter 3. Mucus and Mucins | 27 | ||
| COMPOSITION OF MUCUS AND PHLEGM | 28 | ||
| MUCIN SECRETION AND MUCUS CLEARANCE | 30 | ||
| UPPER AND LOWER AIRWAY MUCUS | 31 | ||
| THERAPY FOR MUCUS CLEARANCE DISORDERS | 31 | ||
| SUMMARY | 32 | ||
| REFERENCES | 33 | ||
| Chapter 4. Cough and Swallowing Dysfunction | 35 | ||
| COUGH AND DYSPHAGIA | 38 | ||
| FUNDAMENTALS OF SWALLOW ASSESSMENT | 38 | ||
| FUNDAMENTALS OF SWALLOWING THERAPY | 40 | ||
| SUMMARY | 41 | ||
| REFERENCES | 41 | ||
| Chapter 5. Vocal Cord Dysfunction, Paradoxic Vocal Fold Motion, or Laryngomalacia? Our Understanding Requires an Interdisciplinary Approach | 43 | ||
| A HISTORICAL PERSPECTIVE | 43 | ||
| FOCUSING ON THE BIG PICTURE | 45 | ||
| WHAT DIAGNOSES ARE IN THE DIFFERENTIAL? | 46 | ||
| HOW DO WE ADDRESS COUGH? | 46 | ||
| DIFFERENCES AMONG PERIODIC OCCURRENCE OF LARYNGEAL OBSTRUCTION DISORDERS | 47 | ||
| ENDOSCOPIC EVALUATION | 48 | ||
| PARADOXIC VOCAL FOLD MOTION | 49 | ||
| VOCAL CORD DYSFUNCTION | 49 | ||
| INTERMITTENT ARYTENOID REGION PROLAPSE | 52 | ||
| THE THREE CATEGORIES OF PERIODIC OCCURRENCE OF LARYNGEAL OBSTRUCTION | 53 | ||
| VOCAL CORD DYSFUNCTION AND MASS PSYCHOGENIC ILLNESS | 56 | ||
| COUGH | 57 | ||
| HYPOTHESES FOR ORIGIN OF SOME LARYNGEAL DISORDERS | 57 | ||
| PULMONARY DIAGNOSTICS | 58 | ||
| VOCAL CORD DYSFUNCTION MANAGEMENT | 60 | ||
| SUMMARY | 62 | ||
| REFERENCES | 63 | ||
| Chapter 6. Evidence for Sensory Neuropathy and Pharmacologic Management | 67 | ||
| CLINICAL EVALUATION | 68 | ||
| TREATMENT OPTIONS | 69 | ||
| PHARMACEUTICALS FOR TREATMENT OF PVVN | 69 | ||
| SUMMARY | 71 | ||
| REFERENCES | 72 | ||
| Chapter 7. The Role of Voice Therapy in the Management of Paradoxical Vocal Fold Motion, Chronic Cough, and Laryngospasm | 73 | ||
| LARYNGOSPASM | 74 | ||
| PARADOXICAL VOCAL FOLD MOTION | 75 | ||
| CHRONIC COUGH | 75 | ||
| SUMMARY | 81 | ||
| APPENDIX 1. PRODUCT REFERENCES FOR RESISTANCE BREATHING DEVICES | 81 | ||
| REFERENCES | 82 | ||
| Chapter 8. Occupational, Environmental, and Irritant-Induced Cough | 85 | ||
| RESPIRATORY TRACT EFFECTS OF IRRITANTS | 85 | ||
| ALLERGEN VERSUS IRRITANT | 86 | ||
| ROLE OF ODOR | 86 | ||
| OCCUPATIONAL, ENVIRONMENTAL, AND IRRITANT-INDUCED COUGH | 88 | ||
| WORLD TRADE CENTER COUGH | 88 | ||
| EVOLUTION OF IRRITANT-INDUCED COUGH | 89 | ||
| IRRITANT-INDUCED COUGH, A TRPPATHY | 90 | ||
| REFERENCES | 92 | ||
| Chapter 9. Reflux and Cough | 97 | ||
| PATHOPHYSIOLOGY OF REFLUX | 98 | ||
| THE LES AND TRANSIENT LES RELAXATION | 98 | ||
| HOW DOES REFLUX AFFECT THE LARYNX AND UPPER AIRWAY? | 100 | ||
| COUGH: REFLUX OR REFLEX? | 100 | ||
| COUGH IN REFLUX: CLINICAL EVALUATION | 101 | ||
| TREATMENT | 103 | ||
| ALGINATE | 104 | ||
| COMPLICATIONS RELATED TO PPI THERAPY | 104 | ||
| PROKINETIC THERAPY | 105 | ||
| SURGERY | 106 | ||
| SUMMARY | 107 | ||
| REFERENCES | 107 | ||
| Chapter 10. Rhinogenic Laryngitis, Cough, and the Unified Airway | 111 | ||
| LARYNGEAL INVOLVEMENT IN THE UNIFIED AIRWAY | 112 | ||
| MUCUS, NEUROLOGIC REFLEXES, AND NEUROGENIC INFLAMMATION | 114 | ||
| DIAGNOSIS OF CHRONIC RHINOGENIC LARYNGITIS | 115 | ||
| MODEL FOR CHRONIC RHINOGENIC LARYNGITIS | 117 | ||
| SUMMARY | 119 | ||
| REFERENCES | 119 | ||
| Chapter 11. Cough Due to Asthma, Cough- Variant Asthma and Non-Asthmatic Eosinophilic Bronchitis | 123 | ||
| DEFINITION, DIAGNOSIS, AND PREVALENCE | 123 | ||
| EXHALED NITRIC OXIDE AS A SURROGATE FOR SPUTUM EOSINOPHILIA | 125 | ||
| PATHOGENESIS | 125 | ||
| DISEASE PROGRESSION | 126 | ||
| TREATMENT | 127 | ||
| SUMMARY | 128 | ||
| REFERENCES | 128 | ||
| Chapter 12. The Spectrum of Nonasthmatic Inflammatory Airway Diseases in Adults | 131 | ||
| CHRONIC BRONCHITIS | 132 | ||
| BRONCHIECTASIS | 135 | ||
| BRONCHIOLITIS IN ADULTS | 140 | ||
| REFERENCES | 143 | ||
| Chapter 13. Pharmacologic Management of Cough | 147 | ||
| ANTITUSSIVES | 147 | ||
| SUMMARY | 153 | ||
| ACKNOWLEDGMENTS | 153 | ||
| REFERENCES | 153 | ||
| Chapter 14. Assessing Efficacy of Therapy for Cough | 157 | ||
| SUBJECTIVE ASSESSMENTS OF COUGH | 158 | ||
| COUGH REFLEX SENSITIVITY TESTING | 160 | ||
| OBJECTIVE COUGH COUNTING | 161 | ||
| HEALTH-RELATED QUALITY OF LIFE | 162 | ||
| SELECTING PATIENT GROUPS FOR TESTING COUGH THERAPIES | 162 | ||
| CLINICAL TRIAL DESIGN | 163 | ||
| SUMMARY | 164 | ||
| REFERENCES | 164 | ||
| Chapter 15. Unexplained Cough in the Adult | 167 | ||
| UNEXPLAINED VERSUS IDIOPATHIC COUGH | 167 | ||
| HOW OFTEN IS CHRONIC COUGH UNEXPLAINED, AND WHAT ARE THE POTENTIAL EXPLANATIONS? | 168 | ||
| HOW SHOULD CLINICIANS AND RESEARCHERS APPROACH THE PROBLEM? | 168 | ||
| WHAT ARE THE PITFALLS IN MANAGEMENT, AND HAVE THEY BEEN AVOIDED? | 170 | ||
| HOW OFTEN WILL CHRONIC COUGH REMAIN TRULY UNEXPLAINED AFTER THE RECOMMENDED MANAGEMENT PROTOCOL HAS BEEN FOLLOWED? | 175 | ||
| WHAT ARE THE POTENTIAL PATHOGENIC MECHANISMS TO EXPLAIN THE TRULY REFRACTORY, UNEXPLAINED COUGH? | 176 | ||
| WHAT MANAGEMENT OPTIONS ARE AVAILABLE FOR THE TRULY REFRACTORY UNEXPLAINED COUGH? | 177 | ||
| SUMMARY | 178 | ||
| REFERENCES | 178 | ||
| Chapter 16. Cough in the Pediatric Population | 181 | ||
| EPIDEMIOLOGY DATA | 182 | ||
| PATHOPHYSIOLOGY | 182 | ||
| ETIOLOGIC FACTORS | 183 | ||
| EVALUATION OF CHILDREN WITH CHRONIC COUGH | 187 | ||
| REFERENCES | 193 | ||
| Chapter 17. Future Directions in Treating Cough | 199 | ||
| ACUTE AND CHRONIC COUGH—THE EXTENT OF THE PROBLEM | 199 | ||
| OPTIMIZING THE EXISTING PROTOCOLS FOR THE MANAGEMENT OF COUGH | 200 | ||
| DEVELOPMENTS IN THE DIAGNOSIS AND TREATMENT OF THE COMMON TRIAD OF COUGH ETIOLOGIES | 201 | ||
| COUGH REFLEX HYPERSENSITIVITY AND ITS ASSOCIATION WITH COMMON ACUTE AND CHRONIC COUGH SYNDROMES | 203 | ||
| THE DEVELOPMENT OF NEW TREATMENTS FOR COUGH | 205 | ||
| SUMMARY | 207 | ||
| REFERENCES | 207 | ||
| Index | 213 |